Evidence map›Paper›PMID 36650038›Full record

ArticleJournal of neurology, neurosurgery, and psychiatry2023

Yaling Jiang, Meidan Wan, XueWen Xiao, Zhuojie Lin, Xixi Liu, Yafang Zhou, Xinxin Liao, Jingyi Lin, Hui Zhou, Lu Zhou and 10 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neurology, neurosurgery, and psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. A molecular perspective of gelsolin amyloidosis: An old foe with new faces.Cellular and molecular life sciences : CMLS · 2026
    Review
  2. Spotlight on Alzheimer's disease and related dementias research in East Asia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Yaling JiangDepartment of Neurology, Xiangya Hospital Central South University, Changsha, Hunan, China.
Meidan WanDepartment of Neurology, Xiangya Hospital Central South University, Changsha, Hunan, China.
XueWen XiaoDepartment of Neurology, Xiangya Hospital Central South University, Changsha, Hunan, China.
Zhuojie LinDepartment of Neurology, Xiangya Hospital Central South University, Changsha, Hunan, China.
Xixi LiuDepartment of Neurology, Xiangya Hospital Central South University, Changsha, Hunan, China.
Yafang ZhouNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University, Changsha, Hunan, China.
Xinxin LiaoNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University, Changsha, Hunan, China.
Jingyi LinEngineering Research Center of Hunan Province in Cognitive Impairment Disorders, Xiangya Hospital Central South University, Changsha, Hunan, China.
Hui ZhouDepartment of Neurology, Xiangya Hospital Central South University, Changsha, Hunan, China.
Lu ZhouDepartment of Neurology, Xiangya Hospital Central South University, Changsha, Hunan, China.
Ling WengDepartment of Neurology, Xiangya Hospital Central South University, Changsha, Hunan, China.
Junling WangDepartment of Neurology, Xiangya Hospital Central South University, Changsha, Hunan, China.ORCID 0000-0001-5117-5204
Jifeng GuoDepartment of Neurology, Xiangya Hospital Central South University, Changsha, Hunan, China.ORCID 0000-0002-3658-3928
Hong JiangDepartment of Neurology, Xiangya Hospital Central South University, Changsha, Hunan, China.ORCID 0000-0002-7646-5950
Zhuohua ZhangInstitute of Molecular Precision Medicine, Key Laboratory of Molecular Precision Medicine of Hunan Province, Xiangya Hospital Central South University, Changsha, Hunan, China.
Kun XiaCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
Jiada LiCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
Beisha TangDepartment of Neurology, Xiangya Hospital Central South University, Changsha, Hunan, China.
Bin JiaoDepartment of Neurology, Xiangya Hospital Central South University, Changsha, Hunan, China shenlu@csu.edu.cn jiaobin@csu.edu.cn.
Lu ShenDepartment of Neurology, Xiangya Hospital Central South University, Changsha, Hunan, China shenlu@csu.edu.cn jiaobin@csu.edu.cn.ORCID 0000-0002-3393-8578
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe pathogenic missense mutations of the gelsolin (

methodIn total, 1192 patients with AD and 1403 controls were screened through whole genome sequencing, and 884 patients with AD were enrolled for validation. Effects of

resultsSix patients with AD with

conclusions

Indexed as

Alzheimer DiseaseCognitive DysfunctionAmyloid beta-PeptidesBiomarkersFrameshift MutationHumansPeptide FragmentsAmyloid beta-PeptidesBiomarkersPeptide FragmentsALZHEIMER'S DISEASE

Identifiers

PMID36650038
PMCPMC10314070
OpenAlexW4317207652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.